FDA‐approved drugs featuring macrocycles or medium‐sized rings
Archiv der Pharmazie · 2025-01 · 358 (1)
DOI: 10.1002/ardp.202400890 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Archiv der Pharmazie, online erschienen am 25.01.2025. Verfasst von Youlong Du und 7 weiteren Autor:innen. Beteiligte Einrichtung: Jiangsu Co-Innovation Center of Efficient Processing and Utilization of Forest Resources, College of Chemical Engineering, Nanjing Forestry Universit…. Hauptthemen laut MEDLINE: Macrocyclic Compounds. Die Arbeit wurde bisher 32-mal zitiert (Crossref) und nennt 176 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Ikerbasque, Basque Foundation for Science, National Research, Development and Innovation Office of Hungary, Qing-Lan Project of Jiangsu Province.
Abstract (Originalsprache)
Macrocycles or medium‐sized rings offer diverse functionality and stereochemical complexity in a well‐organized ring structure, allowing them to fulfill various biochemical functions, resulting in high affinity and selectivity for protein targets, while preserving sufficient bioavailability to reach intracellular compartments. These features have made macrocycles attractive candidates in organic synthesis and drug discovery. Since the 20th century, more than three‐score macrocyclic drugs, including radiopharmaceuticals, have been approved by the US Food and Drug Administration (FDA) for treating bacterial and viral infections, cancer, obesity, immunosuppression, inflammatory, and neurological disorders, managing cardiovascular diseases, diabetes, and more. This review presents 17 FDA‐approved macrocyclic drugs during the past 5 years, highlighting their importance and critical role in modern therapeutics, and the innovative synthetic approaches for the construction of these macrocycles.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Jiangsu Co-Innovation Center of Efficient Processing and Utilization of Forest Resources, College of Chemical Engineering, Nanjing Forestry University, Nanjing, China.
- Institute of Organic Chemistry, Stereochemistry Research Group, HUN-REN Research Centre for Natural Sciences, Budapest, Hungary.
- Department of Pharmaceutical and Medicinal Chemistry, Institute of Pharmacy, Freie Universität Berlin, Berlin, Germany.
- Department of Organic Chemistry I, Faculty of Chemistry, University of the Basque Country UPV/EHU, San Sebastián, Spain.
- IKERBASQUE, Basque Foundation for Science, Bilbao, Spain.
Förderung
- Ikerbasque, Basque Foundation for Science
- National Research, Development and Innovation Office of Hungary
- Qing-Lan Project of Jiangsu Province
- Freie Universität Berlin
- National Natural Science Foundation of China
Zitieren
APA
Du, Y., Semghouli, A., Wang, Q., Mei, H., Kiss, L., Baecker, D., Soloshonok, V. A., & Han, J. (2025). FDA‐approved drugs featuring macrocycles or medium‐sized rings. Archiv der Pharmazie, 358(1). https://doi.org/10.1002/ardp.202400890
Vancouver
Du Y, Semghouli A, Wang Q, Mei H, Kiss L, Baecker D, et al. FDA‐approved drugs featuring macrocycles or medium‐sized rings. Archiv der Pharmazie. 2025;358(1). doi:10.1002/ardp.202400890
BibTeX
@article{Du2025,
author = {Du, Youlong and Semghouli, Anas and Wang, Qian and Mei, Haibo and Kiss, Loránd and Baecker, Daniel and Soloshonok, Vadim A and Han, Jianlin},
title = {FDA‐approved drugs featuring macrocycles or medium‐sized rings},
journal = {Archiv der Pharmazie},
year = {2025},
volume = {358},
number = {1},
doi = {10.1002/ardp.202400890}
}
EUVIMED